Jaypirca received traditional approval for relapsed/refractory CLL/SLL, showing improved progression-free survival compared to investigator's choice therapy. Breyanzi was approved for ...

Please provide your email address to receive an email when new articles are posted on . FDA has approved a portable device for patients with locally advanced pancreatic cancer. A phase 3 trial showed ...

This decision means there are going to be even more forever chemicals on crops like tomatoes, almonds, and oats. Late last month, the EPA approved a new “forever chemical” pesticide for use on food ...

Sibeprenlimab is approved for IgAN treatment, showing a 51.2% reduction in proteinuria in the VISIONARY trial. Administered subcutaneously every four weeks, it inhibits APRIL to reduce IgA levels.

The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Approval of Myqorzo was granted to ...

Cook County approved $7.5 million to make its guaranteed basic income program permanent after a 2022 pilot that paid $500 a month to 3,250 households using federal COVID relief funds. This decision ...

The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk plans to launch the once-daily oral semaglutide in the US in early January ...

Vanda Pharmaceuticals has received FDA approval for Nereus (tradipitant), an oral NK-1 receptor antagonist developed to prevent motion-induced vomiting. The approval makes Nereus the first new ...

The U.S. Environmental Protection Agency has approved another pesticide that contains PFAS, often referred to as “forever chemicals” because they do not break down in the environment. The decision ...

Boncresa is supplied as a 60mg/mL single-dose prefilled syringe for SC injection and Oziltus is supplied as a 120mg/1.7mL single-dose vial for SC injection. Boncresa is approved to treat ...